Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer—a case report and literature review

BACKGROUND: Fruquintinib is a highly selective tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor (VEGFR). At present, it has been approved for third-line therapy for advanced metastatic colorectal cancer in China. Like other small-molecule tyrosine kinase inhibitors, ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Ya-Ya, Chen, Yun-Wang, Wang, Ming-Xing, Zhu, Peng-Fei, Pan, Shuan-Yue, Jiang, Ding-Yi, Chen, Zhe-Ling, Yang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906055/
https://www.ncbi.nlm.nih.gov/pubmed/36760383
http://dx.doi.org/10.21037/tcr-22-1872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906055/
https://www.ncbi.nlm.nih.gov/pubmed/36760383
http://dx.doi.org/10.21037/tcr-22-1872

Ejemplares similares